Advisory Committee to the WNU RT School



Al QaradawiProf. Ilham Al-Qaradawi is Professor of Nuclear Physics at Qatar University and Adjunct Professor of Physics at Texas A&M University in Qatar. She received her Ph.D. working in the field of positron physics from University of London, UK in 1991.
Over the past decade at Qatar University, she has established a positron lab and successfully built the first variable energy slow positron beam in the Middle East. She has also established a radiation measurement lab carrying out research in the area of environmental radiation physics.
She is involved in many research projects and collaborations on local, regional and international levels. Her research is mainly in the field of positron physics working on various types of materials. She is involved with CERN in the Antihydrogen experiment AEGIS. She is also involved environmental radiation research and in physics education research. She represents Qatar in many areas related to nuclear, radiation physics and science education on the regional and international level.
She is a keen educator who is always working to raise the standards of science awareness and teaching particularly in physics. She is the founder of the Qatar Physics Society; through which she regularly holds training workshops for physics teachers and other activities in an effort to spread physics knowledge and nuclear awarenessas well as improve physics education. She has lectured in the World Nuclear University Summer Institute for the past four years.
Prof. Ilham Al-Qaradawi was awarded the Qatar University award for excellence in research in 2004 and the Ahmed Badeeb Prize for Arab Women in Science in 2008.

BONET Henri 

Henri BonentFrom 1997 to 2008, Henri Bonet was CEO of the National Institute for Radioelements (IRE) in Belgium, one of the world leaders for production of medical radioisotopes and for environmental monitoring systems. Following that, he became Senior Advisor to his successor before retiring in July 09.
He graduated in 1968 as Nuclear-Physics Engineer at Liège University and was first with Belgonucleaire for 12 years, as Design Engineer for Light Water Reactor (LWR) fuel management and as Senior Engineer for Safety Analyses for LWRs and fuel cycle industries. He was in charge for 9 months’ training of a Korean team, in radiological protection & safety.
Then for 4 years he headed the system analysis group in the Authorized Inspection Agency Vinçotte, reviewing the licensing for the start up of the four last Belgian PWR.
In 1985, he joined Exxon Nuclear International, later on taken over by SIEMENS-KWU, where he was Manager Contract Administration and Business Development for Services and LWR nuclear fuel sales in Belgium, France and Sweden.
During his career, he was appointed as member of the scientific advisory commission of the Nuclear Safety Agency (FANC), Expert in the National Nuclear Energy Evaluation Commission and Expert for several IAEA, OECD and CEE working groups.
He has been President of the Belgian Nuclear Society and of the Supervisory Board of CIS bio International (currently IBA-Molecular) and he is Director at the Board of the Belgian Nuclear Research Centre CEN/SCK, STERIGENICS and TRANSRAD.

CHEMALY, Carlo Robert

Carlo ChemalyCarlo R. Chemaly is currently business developer at Pharmalead, a family business active in the fields of promotion of pharmaceutical products and medical equipment.
In his career, Mr. Chemaly has worked at the European Commission and as an independent. Experiences at the European Commission have been in the fields of management support (1996-2000, executive assistant, communication officer and deputy quality officer), project management (2003-2006, responsible for project EMIR - European network for Medical Isotopes and beam Research) and finance and management (2006-2009, responsible for budget planning & financial control of Youth, Sports & Citizenship Directorate). As an independent, experiences have included a number of market surveys and a one-year experience (2002) in setting up a company in the field of energy trading.
His experience in the field of isotopes has been whilst managing the EMIR project of the European Commission. Main achievements include the organisation of the 5ICI (5the International Conference on Isotopes) and the joint publication of a Radioisotope Survey. As a result, Mr. Chemaly has remained present in the field, participating on the International Monitoring Steering Committee of 6ICI, the World Council of Isotopes and was lecturer and mentor at the first RI school.
Mr. Chemaly's academic background is in business. He graduated in 2001 from Insead (France) with a M.B.A. (Masters of Business Administration) and in 1996 from the Solvay Business School (University of Brussels, Belgium) with M.Sc. in "Business Engineering".
Having lived in a number of countries (Belgium, Lebanon, The Netherlands, France, Italy, Canada, Singapore, Germany) and having worked at the European Commission Mr Chemaly has developed, in addition to specific language skills, a certain feeling for managing in cross-cultural environments. 


GONZALEZ AbelDr. Abel Julio GONZÁLEZ is an international expert on radiation protection and safety. He is currently Vice-Chair of the International Commission on Radiological Protection, Representative at the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), Member of the Commission of Safety Standards (CSS) of the International Atomic Energy Agency (IAEA), Senior Advisor of the Nuclear Regulatory Authority of the Argentine Government, and a regular member of the Argentine delegation to the IAEA Board of Governors and General Conference.
Over two decades and until 2005, he was the IAEA Director for Radiation, Transport and Waste Safety. Prior to that, he was Director of the Argentine Atomic Energy Commission.
He has published over 200 scientific and technical papers, has contributed towards more than hundred publications of international committees and groups in these subject areas,  has managed several important international projects and has been honored with several international awards including the Sievert Prize (the highest international decoration in radiation protection), the IAEA Distinguished Service Award, the Morgan Award for Health Physics, the Lauriston S. Taylor Lecturer award of the US National Commission of Radiation Protection and Measurements, the IAEA Special Service Award, and the Marie Curie Prize. He also shared the 2005 Nobel Prize granted to the IAEA.
He is a regular lecturer at the international IAEA Post-Graduate Course on Radiation Protection and at the World Nuclear University Summer Institute. Besides his membership of IRPA, he is founding member of the Argentine Radioprotection Society (SAR). IRPA nominated him as President of its XIIth International Congress (IRPA12), which took place in Buenos Aires in October 2008.

KANG Chang-Sun

Chang Sun KangDr. Chang-Sun KANG is a Professor Emeritus of Nuclear Engineering at Seoul National University (SNU). He retired from SNU in 2008 after 30 years of service. Hisareas of expertise were: health physics, radiation shielding, environmental transport of radioactivity, and neutron transport theory. He wrote three text books: Modern Industrial Society and Energy; Introduction to Nuclear Engineering; and Radiation Technology. He also presented more than 150 original papers internationally.
He received his BS from SNU in 1965 and PhD from MIT in 1972 in nuclear engineering. He worked for United Engineers and Constructors, Inc. for 7 years as the Chief Nuclear Engineer, Daewoo Engineering Company for 4 tears as the Executive Managing Director in charge of plant engineering and design before he started his career at SNU as a professor of nuclear engineering.
Previously, he has served as: a Member of Presidential Council on Science and Technology (PCST); the President of Korean Nuclear Society (KNS); a Member of International Nuclear Safety Group (INSAG) of IAEA; the President of Pacific Nuclear Council (PNC); the President of World Council on Isotopes (WCI); and the Vice-President of Korea Atomic Industrial Forum (KAIF).
As of 1 October 2011, he is the Chairman of the Board of Directors of Korea Institute of Nuclear Safety (KINS); a Member of Nuclear Safety Review Board (NSRB) of Emirates Nuclear Energy Corporation (ENEC) of UAE; and a Member of Nuclear Program Advisory Panel (NPAP) of Khalifa University of UAE.

 LEE, Myung Chul  

Myung-Chul LeeProf. Myung-Chul Lee was the first MD researcher who started his resident career in the field of nuclear medicine in Korea. His main research field has been in nuclear neurology. From the beginning of the Department of Nuclear Medicine in SNUH, he devoted himself to the establishment of the department. In 1994, he introduced a PET scanner to SNUH, which was the first PET scanner in Korea. It initiated many outstanding researches and the present boom of PET and PET/CT in Korea. In 1996, the Korean boardmanship of nuclear medicine was started by his critical contribution. He was the 9th president of the World Federation of Nuclear Medicine and Biology (WFNMB) from 2002 to 2006, whose Congress was successfully prepared and held in 2006. In the year 2008, he, as the chairman, also organized the 6th International Conference for the Isotopes which was successfully held in Seoul. At present, he is working as the Director General of Bio-Max Research Institute, and leading an ambitious project to establish the BT-IT Technopark near Inchon International Airport (the BIT Port Project). Through his whole life, he has devoted himself to the development and upgrade of the nuclear medicine of Korea.


Rama 2Dr. N. Ramamoorthy, Ph.D. in Chemistry from University of Bombay, India, is the Senior Advisor to the Director of Bhabha Atomic Research Centre (BARC) in Mumbai, India. He is a professional expert in the field of production and utilisation of radioisotopes and radiopharmaceuticals using research reactors and cyclotrons, and has been involved in several projects and activities related to radiation technology practices and applications. He has nearly 40 years of professional and managerial experience in the above programmes and has held various positions of diverse responsibilities - in India and abroad – related to research and development, production operations and management, international collaborations and cooperation. He has been actively involved in a number of professional bodies such as Indian Nuclear Society and was the President of the Society of Nuclear Medicine, India in 2000-2001.
Dr. Ramamoorthy was the Director of the Division of Physical and Chemical Sciences at the IAEA from October 2003 to March 2011. He was the Manager of the IAEA Programmes on, ‘Nuclear Science’ and ‘Radioisotope Production and Radiation Technology’ and led a team of 40 professionals and 34 general staff serving in the Division.
Dr. Ramamoorthy was Chief Executive of the Board of Radiation and Isotope Technology, a Unit of Dept. of Atomic Energy, Govt. of India, in Mumbai from August 2000 to September 2003. In his adjunct role as Associate Director, Isotope Group, BARC, during the same period, he steered the R&D programmes in BARC in the areas of radioisotope products, radiation technologies, radiation processing and their applications. He has a large number of publications to his credit and has delivered lectures in different forums, e.g. in conferences, seminars and teaching & training events.

SAN LUIS Teofilo O.L.

San LuisDr. Teofilo San Luis currently serves as a Dean of the Asian School of Nuclear Medicine (ASDN) established as the educational arm of the Asia Regional Cooperative Council of Nuclear Medicine (ARCCNM). He obtained his B.Sc. in Letran College, Manila in 1967 and Doctor of Medicine at University of Santo Tomas (UST), Manila in 1972. After residency he was appointed into the UST Faculty of Medicine & Surgery (1975), and eventually promoted to Professor at the age of 46.  He earned his Master of Arts degree in Public Administration from UST (1994) and became holder of the Mariano M. Alimurung Professorial Chair in Medical Education.  He chaired the Department of Nuclear Medicine at St Luke’s Medical Center (2000-2007) and the Section of Nuclear Medicine at the UST Hospital (2006-2010).  He had a short stint at the IAEA Division of Human Health, Nuclear Medicine Section (2002) and conducted various regional training courses in Nuclear Medicine in Asia, Africa & Latin America before becoming Dean of the St Luke’s College of Medicine – William H Quasha Memorial (2002-2005). Previously, he served as the President of various professional & civic organisations including the Radioisotope Society of the Philippines (1983-1984), Philippine Society of Nuclear Medicine (1994-1996), Philippine Thyroid Association (2000-2002) He is currently working as a Director of the International Council for Control of Iodine Deficiency Disorders (ICCIDD); Secretary-Treasurer of the Asia-Oceania Thyroid Association (AOTA); Chair of the Philippine Specialty Board of Nuclear Medicine (PSBNM); and Chair of the Thyroid Council of the Philippines.


Valeriia StaravoitovaDr. Valeriia Starovoitova is a Research Assistant Professor at Idaho State University and project leader of the radio-isotope research program at the Idaho Accelerator Center.  She graduated from Purdue University in 2007 with a doctorate degree in physics. She specialized in molecular biophysics and performed her research at Argonne National Lab’s Advanced Photon Source.  After graduation Dr. Starovoitova joined Idaho State University's Physics Department as a visiting professor of physics. In 2009 she was invited to help establish the radio-isotope research program and form an interdisciplinary medical isotope production group at the Idaho Accelerator Center.
Since then she has been working as the group’s lead physicist developing techniques for photo-nuclear production and separation of medical isotopes. She performed the Center’s first radio-isotope production efficiency experiments and is currently responsible for the development of commercially viable methods of manufacturing medical isotopes using electron LINACs.


Nigel StevensonDr. Stevenson obtained his Ph.D. at the University Of London, UK in 1983 in Nuclear Physics.  Subsequently he worked as a research scientist at TRIUMF, the Canadian Accelerator Facility, with the University of Saskatchewan, Canada group.  Starting in 1990 he headed up the Isotope Production and Applied Technology group at TRIUMF responsible for the production of a wide variety of radioactive medical isotopes for MDS Nordion in addition to specialized isotope production technology.  In 1999 he became the V.P. of Isotope Production and Research for Theragenics Corporation in Atlanta, GA.  In this role he was responsible for installing and operating the world’s largest cyclotron facility (14 machines) used to produce radiochemicals for pharmaceuticals and medical devices.  He also had technical oversight of a large scale stable isotope separation facility in Oak Ridge, TN.  In 2006 he was appointed the Chief Operating Officer of Trace Life Sciences located near Dallas, TX which produces radiochemicals and radiopharmaceuticals.  Since 2007, Dr. Stevenson has been the Chief Operating Officer of Clear Vascular, Inc. (Houston, TX) – a company involved in the production and evaluation of radiotracers for vascular imaging and therapy.  Additionally, he is the CEO of TcNet, LLC, a company that is investigating the use of PET cyclotron systems to produce a number of additional radiochemicals.  Dr. Stevenson serves as the Chief Science Advisor to Advanced Medical Isotope Corporation in Kennewick, WA.  Dr. Stevenson has organized several isotope conferences and conference sessions over the years including the 3rd International Conference on Isotopes held in Vancouver in September 1999 where he served as the Conference Chairperson.  He has also had various roles in the International Isotope Society including that of the President of the Canadian Chapter.


Meera VenkateshDr MeeraVenkatesh, is Director of the Division of Physical and Chemical Sciences in the Department of Nuclear Applications, International Atomic Energy Agency (IAEA). 
She joined the Bhabha Atomic Research Centre (BARC), India, in 1976 after graduating in Chemistry from Bombay University in India. From 1977 she was engaged in the research and development of radiopharmaceuticals at BARC. From 2003, she headed the Radiopharmaceuticals Division at BARC, which was responsible for production of radioisotopes and development of radiopharmaceuticals. She also concurrently served at the Board of Radiation and Isotope Technology (BRIT), the commercial unit of the Department of Atomic Energy, India, from 2000, overseeing the quality control program of radiopharmaceuticals & radiochemicals, and held the post of Senior General Manager at BRIT.
Dr Venkatesh obtained her doctorate degree from the Bombay University in 1986 and worked as a post-doctoral research associate at the University of Missouri, USA, from 1992-94, where she was later invited to act as Associate Professor in 1999. Ms.Venkatesh has published nearly 140 papers in international journals, authored several book chapters & articles and is an editor of three international journals in areas related to radiopharmaceuticals.She was bestowed with the Indian Nuclear Society Award in 2008 for her professional excellence and outstanding contributions in the field of radioisotopes and their applications. In 2009, she received the HomiBhabha Award as the Team Leader for outstanding contributions towards production and supply of radioisotopes and radiochemicals for medical applications.
She is a life member in the various professional bodies of India, such as the Indian Association of Nuclear Chemists and Allied Scientists, Indian Nuclear Society, Society of Nuclear Medicine-India, National Association for Applications of Radioisotopes and Radiation in Industry and Indian Association of Material Chemistry.

 WALTAR Alan E. (Chairman of the Advisory Committee) 

WALTAR AlanDr. Alan E. Waltar recently retired as Senior Advisor to the Pacific Northwest National Laboratory (PNNL) in Richland, WA., having previously served as Director of Nuclear Energy.  He was Professor and Head, Nuclear Engineering, Texas A&M University from 1998 to 2002, where he helped to build that program into the largest Department of Nuclear Engineering in the nation.
Dr. Waltar served as President of the 16,000-member American Nuclear Society during 1994-1995.  He was elected a Fellow of the Society in 1984.  He holds a B.S. in electrical engineering (University of Washington, 1961), an M.S. in nuclear engineering (MIT, 1962), and a Ph.D. in engineering science (University of California, Berkeley, 1966).
His distinguished career with Westinghouse Hanford Company included leadership positions in several areas of advanced reactor technology—mostly related to the regulatory approvals and subsequent operations at the Fast Flux Text Facility (FFTF). He served on the faculty at the University of Virginia where, with Professor Albert Reynolds, he co-authored the Fast Breeder Reactors textbook.  Along with the Russian translation, this book has become one of the standard instructional books for fast spectrum reactors.  It is currently being updated, entitled Fast Spectrum Reactors, with publication by Springer Publishing in 2011. In addition to organizing numerous international technical conferences, Dr. Waltar has published over 75 open literature scientific articles.
Dr. Waltar was instrumental in the formation of the World Nuclear University (WNU) Summer Institute (SI) and has served as a mentor and a member of the faculty for the last seven years.  He also helped organize and participate as lecturer/mentor at the 2010 WNU Radioisotope School in Seoul, South Korea. He was recently inducted into the Washington State Academy of Sciences.
Dr. Waltar authored America the Powerless: Facing our Nuclear Energy Dilemma in 1995 and in 2004 published Radiation and Modern Life:  Fulfilling Marie Curie’s Dream, which articulates the enormous beneficial uses of radiation to society.
Dr. Waltar currently serves as a consultant to the Pacific Northwest National Laboratory, the International Atomic Energy Agency, the U.S. Department of Energy, the U.S. Air Force Scientific Advisory Board, the Advanced Medical Isotope Corporation, and several private nuclear firms.